Clinical Trial Update: Abbott Next Generation Drug Eluting Stent 48mm Study [NA]

View source ↗

Summary

Abbott's next-generation 48mm drug-eluting stent study has completed, and results have been posted. The study addressed treatment of coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Abbott Next Generation Drug Eluting Stent 48mm

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2024-02-12